Oslivir
75 mg
Oseltamivir Phosphate
Segment 04 · Antivirals
Oslivir75 mg
Oseltamivir Phosphate
Oslivir
75 mg
Oseltamivir Phosphate
Antiviral for influenza A and B.
Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation
- Generic composition
- Oseltamivir Phosphate
- Strength
- 75 mg
- Dosage form
- Capsules
- Pack sizes
- 10's
- Manufacturer
- Paramount Pharmaceuticals, Islamabad
- Licence
- DML 000439 · DRAP GMP
- Release
- Batch-tested, with Certificate of Analysis
For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.
Oslivir
How it's made
Capsules are made by blending the powder and filling it into capsule shells. Made in the general production section.
How all our dosage forms are made →- 01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
- 02
Blending
Powder or pellets are blended until the active ingredient is evenly spread.
- 03
Filling
The blend is filled into capsule shells to a set fill weight.
- 04
Weight check and polishing
Capsules are weighed during the run and polished to remove loose powder.
- 05
Packing
Capsules are sealed into blister strips coded with the batch number and expiry date.
Batch release tests
- Uniformity of weight
- Disintegration
- Dissolution
- Assay of the active ingredient
- Microbial limits
Limits for this product are on each batch's Certificate of Analysis.
Anthelmintic, Antifungal, Antimalarial & Antiviral